Deepan Dalal is a Rheumatology/Immunology physician affiliated with Brown University. OpenAlex indexes 37 publications with 745 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
725 Reservoir Ave Ste 204
Cranston, RI 029104451
Telephone
401-563-9825Provider last certified this registry record 20 Jan 2022.
Industry payments
37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year202538 payments$23,634openpaymentsdata.cms.gov ↗
- Janssen Scientific Affairs, LLCProgram year20251 payment
- Amgen Inc.Program year202540 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
53.6%RANK Ligand Inhibitor47%Denosumab100%Part B, office-administered≥36 patientsXanthine oxidase inhibitor1.8%Allopurinol100%Part D≥39 patients+ 5 more classes in this area
Dermatology
13.4%Corticosteroid13.4%Triamcinolone acetonide74%Methylprednisolone26%Part D + Part B≥140 patientsMetabolism & gastrointestinal
8.9%Corticosteroid7.4%Prednisone100%Part D≥169 patientsAntidiarrheal microorganisms0.7%Folic Acid100%Part D≥18 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis
Rheumatology and Therapy
2024 - Sociocultural and Economic Disparities in Physical Therapy Utilization Among Insured Older Adults With Rheumatoid Arthritis
The Journal of Rheumatology
2023 - Medicare expenditures for conventional and biologic disease modifying agents commonly used for treatment of rheumatoid arthritis
Seminars in Arthritis and Rheumatism
2020
Similar KOLs
Other experts from the same institution or the same specialty.
James Klinger, MD
Brown University
Sharon Rounds, MD
Brown University
William Corrao, MD
Brown University
Eric Gartman
Brown University
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”